Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.
A tripeptide of lysine, proline and valine, related to alpha-MSH fragments. Marketed mainly for topical anti-inflammatory and skin/gut applications.
More plausible as a topical/skin-adjacent story than an injectable performance story; appears in wound-healing and inflammation discussions.
| Claim | Strongest evidence |
|---|---|
| Anti-inflammatory / wound healing | R Regulatory only |
| Skin / gut | D Cell / mechanistic |
FDA found no approved-drug component or USP/NF monograph and proposed not adding KPV, citing lack of human safety/effectiveness information.
No human safety/effectiveness data. Marketing claims often imply drug effects without support.
No. FDA found no monograph and proposed not adding it; it is not an established supplement ingredient.
One email when regulatory status changes or strong new evidence lands. Health topics only. Unsubscribe anytime.
Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.